PROVIDER PROFILE · NPI 1780675181

Sumaira AasiMD

PRACTICESTANFORD HEALTH CARESee all providers at this practice →

DermatologyStanford, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,324

Unique beneficiaries

—

Total services

1,865

Distinct HCPCS

Medicare payment

$250K

Peer benchmark

Total Medicare services vs. 1,546 Dermatology providers in CA — below median (cohort median 2,504).

PRESCRIBING · PART D · 2024

Total Rx claims

120

Beneficiaries

—

Total drug cost

$2K

Distinct drugs

Brand share

10.0%

Top prescribed drugs

Cephalexin84 claims

Fluorouracil13 claims

Acetaminophen With Codeine12 claims

Clindamycin Hcl11 claims

QUALITY · MIPS · 2024

Final MIPS score

88.5

Quality

87.1

Cost

69.5

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.57%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$9K

Payment records

By payment type

Consulting Fee$8K

Travel and Lodging$1K

Food and Beverage$332

REFERRAL NETWORK

Where Sumaira Aasi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Roberto Novoa Dermatology · Stanford, CA	100	310
Kerri Rieger Undefined Physician type · Palo Alto, CA	77	273
Jinah Kim Pathology · Palo Alto, CA	70	221
Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA	12	36

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history